University of California/Tufts CTSI
Aug 8, 2025, 17:15
Patent Foramen Ovale and Stroke: David Kent and Andy Wang Break It Down
Vasculearn Network shared an insightful post on LinkedIn:
”ICYMI: PFO and Stroke – Who Benefits from Closure?
About 1 in 4 adults has a PFO, but not everyone needs it closed. A new July 2025 JAMA review reframes PFO closure as targeted, not routine, therapy for select stroke patients.
Key tools guiding treatment:
- RoPE score: Predicts if stroke is PFO-related
- PASCAL system: Adds anatomy to assess stroke causality
Best candidates?
- Age ≤60
- Cryptogenic stroke
- High PASCAL score
- No vascular risk factors
In these patients, closure cuts stroke recurrence risk by up to 90% at 2 years.
Everyone else? Medical therapy still leads with individualized decisions on antiplatelet vs. anticoagulant”
Find the full update on the community.
Read the full article here.
Article: Patent Foramen Ovale and Stroke. A Review
Authors: David M. Kent, Andy Y. Wang
Stay informed on all the scientific advances in hematology with Hemostasis Today.
-
Jul 2, 2026, 19:40Minoo Ahmadinejad: Improving the Recognition of Women and Girls With Hemophilia
-
Jul 2, 2026, 19:26Dhinesh Selvaraju: FDA Expands Access to HYMPAVZI in Hemophilia
-
Jul 2, 2026, 19:13Syed Fahad Hussain: Not Every Low Platelet Count Tells the Same Story
-
Jul 2, 2026, 18:59Indu Thakur: Supporting Blood Donation Through Public Awareness in MSBT
-
Jul 2, 2026, 18:47Vee Townsend: IMHUE Highlights 9 Myths and Facts About Hemophilia B
-
Jul 2, 2026, 17:17Nico Gagelmann: Launching Myths and Facts on Hematology and Cell Therapy
-
Jul 2, 2026, 17:05Haroun Gajraj: Understanding the Technology Behind Spider Vein Treatment
-
Jul 2, 2026, 16:44Ney Carter Borges: Is It Time to Personalize Antiplatelet Therapy?
-
Jul 2, 2026, 16:22Introducing a New Resource for the ITP Community – ITP Support Association